ClearPoint Neuro, Inc.

NASDAQ:CLPT

Medical - Devices

Healthcare
$7.71 +5.30%

+$0.89 today

Market cap
$247.14M
Beta
1.31
P/E (TTM)
-18.0
EPS (TTM)
-$0.98
52W Low $8.27High $30.10

Volume 0.64M

Average 0.67M

CLPT Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

ClearPoint Neuro, Inc.NASDAQ: CLPT

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense dips below year-ago levels

Q1 FY2026 income tax expense of $8K fell 55.6% year over year, behind the +150.0% change in trailing-twelve-month income tax expense. Sequentially, it rose 100.0% from the prior quarter.

Context

  • Income tax expense amounted to 0.1% of revenue in FY2025, up 0.1 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -55.6% toward the trailing-twelve-month pace of +150.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8K+100.0% QoQ
Last fiscal yearDec 2025
$55K— YoY
LTMMar 2026
$45K+150.0% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-55.6%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
55K USD
Year-over-year change
—

Income Tax Expense vs competitors

How CLPT compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +150.0% is the 2nd highest of 8, against a peer median of -77.8%.
  • Income tax expense amounts to 0.1% of revenue for CLPT, versus a peer median of 0.5%.
CLPT Competitors
Income Tax Expense for CLPT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CTKBCytek Biosciences, Inc.LTM Mar 2026$38.06M USD+1060.2%—18.6%
VREXVarex Imaging CorporationLTM Apr 2026$7.4M USD-87.2%-7.9%0.9%
AKBAAkebia Therapeutics, Inc.LTM Mar 2026$1.75M USD——0.8%
AVNSAvanos Medical, Inc.LTM Mar 2026$1.1M USD+107.4%-31.1%0.2%
OFIXOrthofix Medical Inc.LTM Mar 2026$495K USD-77.8%-12.2%0.1%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$45K USD+150.0%—0.1%
SIBNSI-BONE, Inc.LTM Mar 2026$0 USD——0.0%
SNDLSNDL Inc.LTM Mar 2026-CA$1.5M CAD+76.6%—0.2%
CMPSCOMPASS Pathways plcLTM Mar 2026-$5.31M USD-407.7%——
LABStandard BioTools Inc.LTM Mar 2026-$37.75M USD-12276.1%—43.8%
Peer median (excluding CLPT) —-77.8%-12.2%0.5%

Competitors are the stored peer set for CLPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue16.3M20.55M23.96M31.39M36.97M
Cost of Revenue5.18M7.02M10.34M12.27M14.28M
Gross Profit11.12M13.53M13.61M19.12M22.69M
Gross Margin68.2%65.8%56.8%60.9%61.4%
Research & Development9.28M10.89M11.71M12.39M13.9M
Selling, General & Admin15.22M18.97M24.35M26.48M32.96M
Operating Expenses24.5M29.86M36.06M38.87M46.86M
Depreciation & Amortization692K777K1.46M1.9M2.24M
EBITDA(12.75M)(15.58M)(20.63M)(17.01M)(20.86M)
EBITDA Margin-78.2%-75.8%-86.1%-54.2%-56.4%
Operating Income(13.37M)(16.33M)(22.45M)(19.75M)(24.16M)
Operating Margin-82.1%-79.5%-93.7%-62.9%-65.4%
Interest Income00386K872K1.21M
Interest Expense973K81K002.39M
Other Income / Expenses(1.04M)(103K)357K832K(1.32M)
Income Before Tax(14.41M)(16.44M)(22.09M)(18.91M)(25.49M)
Pre-Tax Margin-88.4%-80.0%-92.2%-60.3%-68.9%
Income Tax Expense000055K
Net Income(14.41M)(16.44M)(22.09M)(18.91M)(25.54M)
Net Margin-88.4%-80.0%-92.2%-60.3%-69.1%
EPS (Basic)(0.69)(0.68)(0.90)(0.70)(0.90)
EPS (Diluted)(0.69)(0.68)(0.90)(0.70)(0.90)
Weighted Avg Shares20.73M24.18M24.61M27.03M28.32M
Weighted Avg Shares (Diluted)20.73M24.18M24.61M27.03M28.32M

ClearPoint Neuro, Inc.

NASDAQ:CLPT

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.